Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for veterinary medicinal products: 58th meeting 14 Settembre 2000Press releaseVeterinary Public Statement on Ziagen (Abacavir) - Abacavir hypersensitivity cases following an interruption of therapy 14 Agosto 2000News Committee for Proprietary Medicinal Products (CPMP) 62nd plenary meeting 31 Luglio 2000Press release Changes in the Human Medicines Evaluation Unit and nomination of new Head of Unit 25 Luglio 2000Press releaseHumanMedicines Committee for veterinary medicinal products: 57th meeting 20 Luglio 2000Press releaseVeterinary 4th meeting of the Committee for Orphan Medicinal Products 14 Luglio 2000Press releaseHumanRare diseases Committee for Proprietary Medicinal Products (CPMP) 61st plenary meeting 4 Luglio 2000Press release Personal Message from Mr Fernand Sauer, EMEA Executive Director (29 June 2000) 29 Giugno 2000Press release Committee for veterinary medicinal products: 56th meeting 22 Giugno 2000Press releaseVeterinary Twenty-sixth meeting of the Management Board 9 Giugno 2000Press releaseCorporate 1 … 363 364 365 366 367 Page 367 of 383 368 369 370 371 … 383
Public Statement on Ziagen (Abacavir) - Abacavir hypersensitivity cases following an interruption of therapy 14 Agosto 2000News
Changes in the Human Medicines Evaluation Unit and nomination of new Head of Unit 25 Luglio 2000Press releaseHumanMedicines
4th meeting of the Committee for Orphan Medicinal Products 14 Luglio 2000Press releaseHumanRare diseases
Personal Message from Mr Fernand Sauer, EMEA Executive Director (29 June 2000) 29 Giugno 2000Press release